Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Injectable salvianolate mechanism study in acute cerebral infarction
ChiCTR-TRC-14004433Phase 4Completed
- Sponsor
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of salvianolate in brain infarction and ischemic stroke (2 arms), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: Copeptin, S100 calcium-binding protein B and 18 more. Started Jan 2014; status: completed.
02
Drugs
salvianolate
03
Conditions
brain infarctionischemic stroke
Beyond the preview
Go deeper on ChiCTR-TRC-14004433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004433.